Piper Jaffray reiterated its Underweight rating on MedAssets (NASDAQ:
MDAS). At the same time, the rating agency reduced its price target on the company's stock from $11 to $10. On Monday, MDAS lost 5.29% of its value to finish the day at $12.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.